Navigation Links
Martek Announces Third Quarter 2008 Financial Results
Date:9/4/2008

11,269

Total revenues 88,403 77,846 262,010 224,793

Cost of revenues:

Cost of product sales 47,334 44,217 143,010 133,003

Cost of contract

manufacturing sales 4,374 3,681 10,826 11,296

Total cost of

revenues 51,708 47,898 153,836 144,299

Gross margin 36,695 29,948 108,174 80,494

Operating expenses:

Research and development 6,278 6,576 19,078 18,551

Selling, general and

administrative 13,554 11,563 40,769 32,683

Amortization of

intangible assets 1,919 1,602 5,475 4,521

Restructuring charge - 146 - 747

Other operating expenses 341 156 590 1,252

Total operating

expenses 22,092 20,043 65,912 57,754

Income from operations 14,603 9,905 42,262 22,740

Interest income (expense)

and other, net 337 (288) 863 (1,162)

Income before income

tax provision 14,940 9,617 43,125 21,578

Income tax provision 5,608 3,491 15,922 7,833

Net income $9,332 $6,126 $27,203 $13,745

Basic earnings per share $0.28 $0.19 $0.83 $0.43

Diluted earnings per

share $0.28 $0.19 $0.82 $0.42

Shares used in computing

basic earnings per

share 33,016 32,273 32,892 32,231

Shares used in computing

diluted earnings per

share 33,408 32,519 33,235 32,463

'/>"/>
SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Martek Announces Fourth Quarter and FY 2007 Financial Results
9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... SHANGHAI , May 6, 2015 Dr ... institute of Massey University, will deliver a speech at the ... 24-25 at the Shanghai New Expo Center.  ... he will introduce to attendees the topic: ,Potato Starch: ... Bulk-ingredients and Smart Foods., Co-editor of a ...
(Date:5/5/2015)... DIEGO AND TORONTO, May 5, 2015 /PRNewswire/ - Aptose Biosciences ... today reported financial results for the three months ended ... specified otherwise, all amounts are in Canadian dollars. ... its fiscal year end from May 31 to December ... interim period being reported is for the three months ...
(Date:5/5/2015)... Mich. (PRWEB) May 05, 2015 ... publishing services to develop custom course materials for smaller ... annual enrollments as low as 200 students. , ... a broader range of higher education instructors,” said Jeff ... the country, we can do our part to make ...
(Date:5/5/2015)... May 05, 2015 The Academy of ... of Indiana, led by Indiana Gov. Mike Pence, has ... AMA Foundation will host a Family Fest and aviation ... proceeds will benefit the Wounded Warrior Project. , National ... of Model Aeronautics—the country’s foremost organization for model aviation—to ...
Breaking Biology Technology:Potato Starch: A Potential Source for the Creation of Next Generation Bulk-ingredients and Smart Foods 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 8Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2State of Indiana proclaims August 15 as Model Aviation Day 2
... testing market is projected to grow at a healthy pace to ... growing incidence of genetic diseases and growing consumer awareness and rising ... ... (PRWEB) October 30, 2008 -- Genetic testing, which of-late has been ...
... at the National Institute of Standards and ... microscope to quickly and cheaply analyze nanoscale ... Scanning Optical Microscope (TSOM) imaging, the technique ... control and biotechnology. , Optical microscopes are ...
... PALO ALTO, Calif., Oct. 29 Telik, Inc.,(Nasdaq: ... an interrupted Phase 3,randomized study of Telcyta (canfosfamide ... PLD alone in second-line,therapy in platinum refractory, primary ... of platinum status are,provided below)., On an ...
Cached Biology Technology:Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3Nanoscale dimensioning is fast, cheap with new NIST optical technique 2Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer 2Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer 3Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer 4
(Date:3/31/2015)... --  Guidepoint , a leading global research services firm, ... TRACKER, part of the Guidepoint TRACKER suite ... device and therapeutics markets. The Post-Surgical Pain Management TRACKER ... share, and adoption rates across three major modalities used ... The Post-Surgical Pain Management TRACKER will provide length ...
(Date:3/24/2015)... WASHINGTON , March 24, 2015   NexID ... applications with critical security-authentication needs, today announced the beginning ... fake-finger-detection (FFD) solution. The company, based in ... announcement at the three-day Connect:ID Expo, which began here ... NexID said version 2.0 of its SDK boosts ...
(Date:3/23/2015)... --NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet, ... March 30 th . The new ... York markets. Gino Pereira ... new ad campaign following the recent initial shipment of Wocket ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... forever change the way some of the most widely used ... Science , he and his partner in the research, ... a reality. The discovery appears in the October 28, 2011 ... synthesis of homogeneous ultra-low molecular weight heparins." Linhardt, the ...
... Naval Research (ONR) will promote its science and technology ... (HACU) 25th Annual Conference, Oct. 29-31, in San Antonio. ... the Department of the Navy,s (DoN) science and technology ... funding, internship and fellowship opportunities. It is aimed at ...
... how mice recover after H1N1 flu, researchers at Harvard Medical ... A*STAR of Singapore, have cloned three distinct stem cells from ... can form into the lung,s alveoli air sac tissue. What,s ... are rapidly deployed in a dynamic process of lung regeneration ...
Cached Biology News:Discovery announced in Science represents 'new paradigm' in the way drugs can be manufactured 2Discovery announced in Science represents 'new paradigm' in the way drugs can be manufactured 3Lung stem cells offer therapeutic clues 2
...
... PI is used in conjuction with Annexin ... the earlier stages of apoptosis (Annexin V ... in later stages of apoptosis or already ... is detected in the orange range of ...
... RPMI 1640 with 2 mM L-glutamine and harvested ... order to keep the antigens in their native ... cells are arrayed on a 12-well (5 mm) ... treated to enhance cellular attachment and to minimize ...
... a software package that provides crystallographers ... custom buffer creation, set-up of experimental ... trials. The software helps crystallographers through ... protein crystallography: Design ...
Biology Products: